Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2025-08-07 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
第四届第五次职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the Fourth Fifth Workers' Representative Congress of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, and the election of a workers' representative director to the board. It references compliance with company law and stock exchange listing rules, and mentions a related announcement published separately. The document is not a full report, financial statement, or detailed management discussion, but rather a specific announcement about board/management changes, specifically the election of a board member representing workers. It is not an AGM information document since it is a workers' representative meeting, not a general shareholders' meeting. The document length is short (1014 characters), and it contains substantive content about management changes rather than just announcing a report publication. Therefore, the best fitting category is Board/Management Information (MANG).
2025-08-07 Chinese
网络投票实施细则
Regulatory Filings Classification · 95% confidence The document is titled '网络投票实施细则' which translates to 'Network Voting Implementation Rules'. It details the procedures and rules for shareholders to vote via an online system at the company's shareholder meetings. It includes sections on voting mechanisms, timing, vote counting, and legal compliance. The document is a formal announcement of internal governance rules related to shareholder voting processes, not a report of financial results, management changes, or meeting results. It is not a report publication announcement or a certification. It is a regulatory announcement about internal procedures for shareholder voting, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like AGM materials or voting results announcements. The document length is 2572 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2025-08-07 Chinese
公司章程
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes comprehensive sections on company general provisions, business scope, share issuance, shareholder rights, board and management structure, financial accounting, audit, and other governance matters. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Beijing Stock Exchange listing rules. The document is lengthy (15,000 characters) and contains substantive content about company governance, shareholder meetings, board responsibilities, and financial accounting systems. It is not a report of financial results, audit report, or announcement of voting results, but rather a governance document outlining the internal rules and structure of the company. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-07 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held on August 6, 2025, including the participants, questions asked, and company responses about R&D progress, strategic outlook, and future plans. The content is a summary of an investor relations meeting or activity rather than a formal financial report or regulatory filing. It does not contain financial statements, audit information, or voting results. It is not a transcript of a conference call but rather a record of an investor relations event. Therefore, the document best fits the category of Investor Presentation (IP), which includes detailed presentations or records for investors focusing on company strategy and financial outlook.
2025-08-07 Chinese
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules'. It details the internal management rules and responsibilities of the board secretary, including qualifications, duties, appointment, and removal procedures. It references company law and securities regulations but does not contain financial data, earnings, or audit information. It is a governance-related document outlining internal rules and procedures for a specific corporate role. The document length is 2757 characters, which is relatively short and focused on governance policies rather than financial reporting or announcements. Therefore, it fits best under Governance Information (CGR).
2025-08-07 Chinese
承诺管理制度
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Sichuan Zitonggong Pharmaceutical Co., Ltd. regarding the approval and content of a revised internal management system called the 'Commitment Management System'. It details the board meeting resolution, voting results, and the main content of the system, including rules for commitments by controlling shareholders, related parties, and the company itself. The document is a regulatory announcement about internal governance policies and procedures, not a financial report, earnings release, or shareholder meeting materials. It does not contain financial statements or results, nor is it a notice of voting results or a proxy solicitation. It is a regulatory filing disclosing corporate governance-related internal rules and compliance with securities laws and stock exchange regulations. Given the nature and length of the document, it fits best under Regulatory Filings (RNS).
2025-08-07 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.